A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia

Cancer Genetics and Cytogenetics

Volumn 168, Issue 1, 2006, Pages 69-72

  Sandlund, John T ^a   Kastan, Michael B ^a   Kennedy, Wren ^a   Behm, Frederick ^a   Entrekin, Elaine ^a   Pui, Ching Hon ^a   Kalwinsky, David T ^b   Raimondi, Susana C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Johnson City Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN BCL 6; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; BONE MARROW; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME REARRANGEMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCUS; GENE PROBE; HUMAN; HUMAN TISSUE; KARYOTYPE; MOLECULAR CLONING; PRIORITY JOURNAL; SCHOOL CHILD; B CELL LEUKEMIA; CHILD; CHROMOSOME 3; CHROMOSOME 8; GENE TRANSLOCATION; GENETICS; KARYOTYPING; ONCOGENE MYC;

ATAXIA TELANGIECTASIA;

ATAXIA TELANGIECTASIA; BURKITT LYMPHOMA; CHILD; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; FEMALE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; TRANSLOCATION, GENETIC;

EID: 33746448857     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.12.013     Document Type: Article

References (26)

1. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours (2001), IARC Press, Lyon
2. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., and Croce C.M. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79 (1982) 7824-7827
3. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., and Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 79 (1982) 7837-7841
4. Magrath I.T., and Bhatia K. Pathogenesis of small noncleaved cell lymphomas (Burkitt's lymphoma). In: Magrath I.T. (Ed). The non-Hodgkin's lymphomas. 2nd ed (1997), Arnold, London 385-409
5. Croce C.M., Erikson J., Ar-Rushdi A., Aden D., and Nishikura K. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Proc Natl Acad Sci U S A 81 (1984) 3170-3174
6. Croce C.M. Role of chromosome translocations in human neoplasia. Cell 49 (1987) 155-156
7. Sandlund J.T., Neckers L.M., Schneller H.E., Woodruff L.S., and Magrath I.T. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences. Cancer Res 53 (1993) 127-132
8. Gu W., Bhatia K., Magrath I.T., Dang C.V., and Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264 (1994) 251-254
9. Dalla-Favera R., Ye B.H., Cattoretti G., Lo Coco F., Chang C.C., Zhang J., Migliazza A., Cechova K., Niu H., Chaganti S., Chen W., Louie D.C., Offit K., and Chaganti R.S. BCL-6 in diffuse large-cell lymphomas. Important Adv Oncol (1996) 139-148
10. Dalla-Favera R., Migliazza A., Chang C.C., Niu H., Pasqualucci L., Butler M., Shen Q., and Cattoretti G. Molecular pathogenesis of B cell malignancy: the role of BCL-6. Curr Top Microbiol Immunol 246 (1999) 257-263 discussion 263-5
11. Pasqualucci L., Bereschenko O., Niu H., Klein U., Basso K., Guglielmino R., Cattoretti G., and Dalla-Favera R. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma 44 Suppl 3 (2003) S5-S12
12. Pasqualucci L., Migliazza A., Basso K., Houldsworth J., Chaganti R.S., and Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101 (2003) 2914-2923
13. Phan R.T., and Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432 (2004) 635-639
14. Dent A. B-cell lymphoma: suppressing a tumor suppressor. [News]. Nat Med 11 (2005) 22
15. Lones M.A., Sanger W.G., Le Beau M.M., Heerema N.A., Sposto R., Perkins S.L., Buckley J., Kadin M.E., Kjeldsberg C.R., Meadows A., Siegel S., Finlay J., Bergeron S., Cairo M.S., and Children's Cancer Group Study CCG-E08. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. J Pediatr Hematol Oncol 26 (2004) 169-178
16. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep 5 (2004) 772-776
17. Brown L.R., Coulam C.M., and Reese D.F. Ataxia-telangiectasia (Louis-Bar syndrome). Semin Roentgenol 11 (1976) 67-70
18. Gatti R.A. Ataxia-telangiectasia. Dermatol Clin 13 (1995) 1-6
19. Kastan M.B., and Lim D.S. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1 (2000) 179-186
20. Kastan M.B., and Lim D.S. Multiple signaling pathways involving ATM. Cold Spring Harb Symp Quant Biol 65 (2000) 521-526
21. Kastan M.B., Lim D.S., Kim S.T., and Yang D. ATM: a key determinant of multiple cellular responses to irradiation. Acta Oncol 40 (2001) 686-688
22. Shiloh Y., and Kastan M.B. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 83 (2001) 209-254
23. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
24. Gumy-Pause F., Wacker P., and Sappino A.P. ATM gene and lymphoid malignancies. Leukemia 18 (2004) 238-242
25. Sandoval C., and Swift M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 31 (1998) 491-497
26. Taylor A.M., Metcalfe J.A., Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438